Market Movers

China Vanke’s Stock Price Plummets to 5.95 HKD, Recording a 6.30% Drop

By February 13, 2025 No Comments

China Vanke (2202)

5.95 HKD -0.40 (-6.30%) Volume: 238.97M

China Vanke’s stock price is currently at 5.95 HKD, witnessing a dip of -6.30% this trading session, despite a +12.48% YTD increase. With a trading volume of 238.97M, the fluctuations in the stock performance of China Vanke (2202) present intriguing opportunities for investors.


Latest developments on China Vanke

Today, China Vanke (H) stock price saw a significant jump following reports that China is considering a funding plan to assist the company. This news comes after the state shareholder provided a $383 million loan to China Vanke, further boosting investor confidence. Despite JPM’s decision to sell on the rebound due to concerns over China Vanke’s valuation, the market remains optimistic about the company’s future prospects.


A look at China Vanke Smart Scores

FactorScoreMagnitude
Value5
Dividend1
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has received a high score of 5 for its value, indicating a positive long-term outlook in terms of its financial health and valuation. This suggests that the company is undervalued and may present a good investment opportunity for those looking for value stocks in the property development sector.

On the other hand, China Vanke (H) received a low score of 1 for its dividend, which may not be attractive for income-seeking investors. However, with moderate scores in growth, resilience, and momentum, the company shows potential for steady growth and stability in the future despite some fluctuations in performance.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars